UPDATE: Goldman Sachs Starts Twist Bioscience (TWST) at Neutral
Tweet Send to a Friend
(Updated - June 4, 2021 4:28 AM EDT)
Goldman Sachs analyst Matthew Sykes initiates coverage on Twist Bioscience (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Matthew Sykes initiates coverage on Twist Bioscience (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
